[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

被引：0
|
作者：
Alina Berriolo-Riedinger
Claude Touzery
Jean-Marc Riedinger
Michel Toubeau
Bruno Coudert
Laurent Arnould
Christophe Boichot
Alexandre Cochet
Pierre Fumoleau
François Brunotte
机构：
[1] Centre Georges Francois Leclerc,Department of Nuclear Medicine
[2] Centre Georges Francois Leclerc,Department of Medical Oncology
[3] Centre Georges Francois Leclerc,Department of Pathology
[4] CNRS UMR 5158,undefined
[5] 1rue du Professeur Marion,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷
关键词：
F-fluorodeoxyglucose; Breast cancer; PET scan; Monitoring therapy; SUV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1915 / 1924
页数：9
相关论文
共 50 条
  • [31] The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Tiberio, Paola
    Antunovic, Lidija
    Gaudio, Mariangela
    Vigano, Alessandro
    Pastore, Manuela
    Miggiano, Chiara
    Jacobs, Flavia
    Benvenuti, Chiara
    Farina, Elisabetta
    Chiti, Arturo
    Santoro, Armando
    De Sanctis, Rita
    NUTRIENTS, 2023, 15 (01)
  • [32] Monitoring preoperative chemotherapy response in patients with osteosarcoma using [18F]FDG-PET
    Kotzerke, J
    BrechtKrauss, D
    Schulte, M
    Guhlmann, CA
    Kinzl, W
    Reske, SN
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 476 - 476
  • [33] Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT
    Bulut, Gulcan
    Atilgan, Hasan Ikbal
    Cinarer, Gokalp
    Kilic, Kazim
    Yikar, Deniz
    Parlar, Tuba
    PLOS ONE, 2023, 18 (09):
  • [34] Usefulness of 18F FDG PET CT in the assessment of neoadjuvant chemotherapy in Esophageal Cancer
    Navarro Fernandez, J.
    Frutos Esteban, L.
    Mohamed Salem, L.
    Porras Martinez, M.
    Munitis, V.
    Ruiz Merino, G.
    Marin Vera, M.
    Alcaraz Banos, M.
    Claver Valderas, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S355 - S355
  • [35] 18F-FDG-PET/CT and MRI in the assessment of neoadjuvant chemotherapy treatment response in breast cancer. Correlation with pathological response
    Guarin, Marco
    Eugenia Azar, M.
    Tinetti, Carolina
    Dolores Mansilla F, M.
    Namias, Mauro
    Carballo, Pilar
    Santamarina, Lucia
    Cavallero, Jorgelina
    Moreau, Romina
    Gonzalez, Christian
    Caceres, Valeria
    Gonzalez, Eduardo
    Bruno, Gabriel
    CANCER RESEARCH, 2021, 81 (04)
  • [36] [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer
    Been, Lukas B.
    Hoekstra, Harald J.
    Suurmeijer, Albert J. H.
    Jager, Pieter L.
    van der Laan, Bernard F. A. M.
    Elsinga, Philip H.
    ORAL ONCOLOGY, 2009, 45 (12) : E211 - E215
  • [37] 18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis
    Wu, Yilin
    Li, Yanling
    Chen, Bin
    Zhang, Ying
    Xing, Wanying
    Guo, Baoliang
    Wang, Wan
    ONCOLOGIST, 2024, 29 (12): : e1646 - e1655
  • [38] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Joan Duch
    David Fuster
    Montserrat Muñoz
    Pedro Luís Fernández
    Pilar Paredes
    Montserrat Fontanillas
    Flavia Guzmán
    Sebastià Rubí
    Francisco Juan Lomeña
    Francesca Pons
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1551 - 1557
  • [39] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Duch, Joan
    Fuster, David
    Munoz, Montserrat
    Luis Fernandez, Pedro
    Paredes, Pilar
    Fontanillas, Montserrat
    Guzman, Flavia
    Rubi, Sebastia
    Juan Lomena, Francisco
    Pons, Francesca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1551 - 1557
  • [40] SUV max of 18F FDG-PET/CT: A predictive factor associated with pathologic complete response in luminal HER2-negative breast cancer patients (receiving neoadjuvant chemotherapy)
    Lee, I. H.
    Lee, S. J.
    Lee, J.
    Lee, R. K.
    Jung, J.
    Park, H.
    Lee, S-w
    Chae, Y. S.
    CANCER RESEARCH, 2019, 79 (04)
12345